Mycobacterial MenG: Partial Purification, Characterization, and Inhibition-Reference-Cited by-同舟云学术

Mycobacterial MenG: Partial Purification, Characterization, and Inhibition

Published:2022-11-23 Issue:12 Volume:8 Page:2430-2440
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Pujari Venugopal¹,Rozman Kaja²,Dhiman Rakesh K.¹,Aldrich Courtney C.²^ORCID,Crick Dean C.¹^ORCID

Affiliation:

1. Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, United States

2. Department of Medicinal Chemistry, University of Minnesota, 308 Harvard Street Southeast, Minneapolis, Minnesota 55455, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00190

Reference62 articles.

1. Crystal Structure of Mycobacterium tuberculosis MenB, a Key Enzyme in Vitamin K2 Biosynthesis

2. Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence

3. Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases

4. Menaquinone as a potential target of antibacterial agents

5. Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling bacterial stress responses: implications for next-generation antimicrobial solutions;World Journal of Microbiology and Biotechnology;2024-07-29

2. Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope;Advances in Microbial Physiology;2023